SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : The New QLogic (ANCR) -- Ignore unavailable to you. Want to Upgrade?


To: Craig Stevenson who wrote (17754)8/18/1998 2:03:00 PM
From: Mark J. Hardie  Read Replies (2) | Respond to of 29386
 
Found an interesting article in the July 1998 issue of Network Magazine and thought I would share it since I haven't seen it mentioned here (it's a really boring magazine, but it seemed like a good one to get considering my investment in ANCR and somehow I managed to weasel a free subscription out of them). It's about a company called Incyte Pharmaceuticals and their search for more bandwidth. I almost didn't read it because...well just because the magazine practically screams "SKIM ME" at someone like me...but then the passage that follows below caught my eye.

<<.As a backbone solution, Kwan briefly considered ATM. "In previous experience with ATM, I didn't find that it provided bandwidth unless you implemented it right to the server, which would have been expensive and complicated." And Fibre Channel was "too much of a niche market," he says, noting that he wouldn't have been able to get NICS for all the equipment that would have needed them.>>

Is this (pick one) one/a/the reason why Ancor is having so much trouble selling product...lack of NIC's (or the perception of lack of NIC's)?

Mark

PS. You might be able to find the article at (I looked briefly but the server was down?): networkmagazine.com